Symrise Acquires Kaden Biochemicals

Symrise has acquired Kaden Biochemicals GmbH, a company that develops and produces high purity active ingredients from plant material.

“This acquisition gives us a good position on the highly attractive market for functional food and nutraceuticals,” said Gerold Linzbach, CEO, Symrise. “As a result, we can now offer a much broader spectrum, and we can present ourselves even more strongly as a source of comprehensive sensory solutions for nearly every challenge on the market.”

More in Suppliers & Services